Calculating the power or sample size for the logistic and proportional hazards modelsSCHOENFELD, David A; BORENSTEIN, Michael.Journal of statistical computation and simulation (Print). 2005, Vol 75, Num 10, pp 771-785, issn 0094-9655, 15 p.Article

Infections with Vibrio vulnificusBORENSTEIN, Michael; KERDEL, Francisco.Dermatologic clinics. 2003, Vol 21, Num 2, issn 0733-8635, v, 245-248 [5 p.]Article

Clozapine and haloperidol in moderately refractory schizophrenia: A 6-month randomized and double-blind comparisonKANE, John M; MARDER, Stephen R; BORENSTEIN, Michael et al.Archives of general psychiatry. 2001, Vol 58, Num 10, pp 965-972, issn 0003-990XArticle

Quantification of a novel retinoic acid metabolism inhibitor, 4-(1H-imidazol-1-yl)retinoic acid (VN/14-1RA) and other retinoids in rat plasma by liquid chromatography with diode-array detectionCHUNYU WU; NJAR, Vincent; BRODIE, Angela et al.Journal of chromatography. B. 2004, Vol 810, Num 2, pp 203-208, issn 1570-0232, 6 p.Article

Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized TrialsKISHIMOTO, Taishiro; ROBENZADEH, Alfred; LEUCHT, Claudia et al.Schizophrenia bulletin. 2014, Vol 40, Num 1, pp 192-213, issn 0586-7614, 22 p.Article

Long-Acting Injectable Versus Oral Antipsychotics in Schizophrenia: A Systematic Review and Meta-Analysis of Mirror-Image StudiesKISHIMOTO, Taishiro; NITTA, Masahiro; BORENSTEIN, Michael et al.The Journal of clinical psychiatry. 2013, Vol 74, Num 10, pp 957-965, issn 0160-6689, 9 p.Article

Meta-Analysis and SubgroupsBORENSTEIN, Michael; HIGGINS, Julian P. T.Prevention science (Print). 2013, Vol 14, Num 2, pp 134-143, issn 1389-4986, 10 p.Article

National depressive and manic-depressive association consensus statement on the use of placebo in clinical trials of mood disordersCHAMEY, Dennis S; NEMEROFF, Charles B; EVANS, Dwight L et al.Archives of general psychiatry. 2002, Vol 59, Num 3, pp 262-270, issn 0003-990XArticle

Use of hydrophilic hydroxypropyl methacrylate/ethylene glycol methacrylate packing material in size-exclusion chromatographyVIANNA-SOARES, Cristina D; KIM, Cherng-Ju; BORENSTEIN, Michael R et al.Journal of AOAC International. 2002, Vol 85, Num 6, pp 1308-1315, issn 1060-3271, 8 p.Article

Determination of bioactive eicosanoids in brain tissue by a sensitive reversed-phase liquid chromatographic method with fluorescence detectionHONGFEI YUE; STRAUSS, Kenneth I; BORENSTEIN, Michael R et al.Journal of chromatography. B. 2004, Vol 803, Num 2, pp 267-277, issn 1570-0232, 11 p.Article

A liquid chromatography/mass spectrometric method for simultaneous analysis of arachidonic acid and its endogenous eicosanoid metabolites prostaglandins, dihydroxyeicosatrienoic acids, hydroxyeicosatetraenoic acids, and epoxyeicosatrienoic acids in rat brain tissueHONGFEI YUE; JANSEN, Susan A; STRAUSS, Kenneth I et al.Journal of pharmaceutical and biomedical analysis. 2007, Vol 43, Num 3, pp 1122-1134, issn 0731-7085, 13 p.Article

Gas chromatographic method using nitrogen-phosphorus detection for the measurement of tramadol and its O-desmethyl metabolite in plasma and brain tissue of mice and ratsQIHAI TAO; STONE, Dennis J; BORENSTEIN, Michael R et al.Journal of chromatography. B, Biomedical sciences and applications. 2001, Vol 763, Num 1-2, pp 165-171, issn 1387-2273Article